Finally, since a downregulation of the passenger strand miR-122* was observed in most HCC patients, causing the activation of the p53 axis [20], miR-122* replacement might also be envisaged for the treatment of HCC. The gene discussed is TP53; the disease is hepatocellular carcinoma.